December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreFebruary 18, 2026
According to our projections, the clinical trial drug sourcing market was valued at USD 2.07 billion in 2025 and reached USD 2.16 billion in 2026, projected to grow to USD 3.14 billion by 2035, expanding at a CAGR of 4.24% (2026–2035)....
February 17, 2026
The global cystic fibrosis therapeutics market expected to reach USD 44.72 billion by 2035, growing at a CAGR of 14.24% over the forecast period. In 2024, North America dominated the market, while Asia-Pacific is set for the fastest growth. CFTR modulators led by drug class, with pancreatic enzyme supplements projected for the highest CAGR. Oral ad...
February 17, 2026
Projections indicate that, drugs industry is projected to rise from USD 1688.14 billion in 2025 to USD 3034.63 billion by 2035, reflecting a CAGR of 6.04% over the next decade. Around the world, an increasing geriatric patients with chronic conditions like cardiovascular diseases, diabetes, and cancer, with technological advancements in drug develo...
February 17, 2026
According to market projections, the global bispecific antibody market, valued at USD 17.24 billion in 2025, is anticipated to reach USD 662.84 billion by 2035, growing at a CAGR of 44.04% over the next decade. The bispecific antibody market is expanding due to increasing occurrences of cancer as well as rising developments. North America led the m...
February 17, 2026
According to market projections, the subcutaneous biologics sector is expected to grow from USD 2.1 billion in 2025 to USD 6.01 billion by 2035, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therapy bolster the market. North America dominated the global market owing to its advanced healthcare infr...
February 17, 2026
Market insights predict, the stem cell reconstructive industry is expected to grow from USD 1.88 billion in 2025 to USD 12.48 billion by 2035, driven by a CAGR of 20.81%. Growing cases of chronic diseases like heart conditions, diabetes, neurodegenerative disorders, and the demand for personalized medicine are driving the global market growth. Nort...
February 17, 2026
Our projections indicate that, the drug desensitization market was valued at USD 670.03 million in 2025 and is estimated to reach USD 724.57 million in 2026, further projected to grow to USD 1,465.41 million by 2035, expanding at a CAGR of 8.14% during 2026–2035...
February 17, 2026
Our projections indicate that, the cold pain therapy OTC products market was valued at USD 1.57 billion in 2025 and reached USD 1.65 billion in 2026, and is projected to grow to USD 2.57 billion by 2035, expanding at a CAGR of 5.04% during 2026–2035....
February 16, 2026
According to market projections, the global cell therapy human raw materials market, valued at USD 3.56 billion in 2024, is anticipated to reach USD 22.75 billion by 2034, growing at a CAGR of 22.38% over the next decade. The growing demand for personalized medicine increases the demand for human raw materials required in cell therapies....
February 16, 2026
The cell therapy raw materials market size is calculated at USD 6.76 bn in 2025 is to hit USD 60.49 bn by 2035. In December 2024, PHC Corporation will unveil its LiCellGrow device, offering real-time insights into cell therapy production. FUJIFILM invested USD 200 million in 2023 to expand CDMO capabilities, while Bayer AG opened a $250 million fac...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com